Journal Wrap

Kim A. Eagle, MD, MACC

The hottest research from various peer-reviewed journals – handpicked weekly by the Editorial Board led by Kim A. Eagle, MD, MACC.

'Real-World' Prolonged DAPT Use Associated With Reduced Benefits, Greater Harm: NCDR Study

Prolonged use of DAPT following PCI may be associated with reduced benefits and greater harms in "real-world" clinical practice vs. the DAPT Study, according to a recent study using data from ACC's CathPCI Registry. The study by Neel M. Butala, MD, MBA, et al., was published in Circulation.

ACC EP Device Implant Registry: ICD Implantations Down Among Patients Not Meeting NCD Criteria After DOJ Investigation

There was a rapid reduction in ICDs placed among patients with a diagnosis of a recent acute myocardial infarction (AMI) or recent heart failure (HF) after a Department of Justice (DOJ) investigation of the use of ICDs, according to a study published in the Journal of Cardiac Failure.

STS/ACC TVT Registry: Patient-Reported vs. Physician-Estimated Symptoms in TAVR

Physicians do a poor job of estimating symptoms and functional status in patients with severe aortic stenosis undergoing TAVR, emphasizing the importance of collecting patient-reported health status, according to a study published in the European Heart Journal: Quality of Care & Clinical Outcomes.

AXIOMATIC-TKR: Factor XIa Inhibitor Milvexian For VTE Prevention

The novel factor XIa inhibitor milvexian is effective in the prevention of venous thromboembolism (VTE) in patients undergoing knee arthroplasty, according to a study presented at AHA 2021 and published in the New England Journal of Medicine.

Clinical Topics: Anticoagulation Management, Arrhythmias and Clinical EP, Cardiac Surgery, Cardiovascular Care Team, Congenital Heart Disease and Pediatric Cardiology, COVID-19 Hub, Dyslipidemia, Heart Failure and Cardiomyopathies, Invasive Cardiovascular Angiography and Intervention, Prevention, Pulmonary Hypertension and Venous Thromboembolism, Anticoagulation Management and Atrial Fibrillation, Anticoagulation Management and Venothromboembolism, Genetic Arrhythmic Conditions, SCD/Ventricular Arrhythmias, Atrial Fibrillation/Supraventricular Arrhythmias, Aortic Surgery, Cardiac Surgery and Arrhythmias, Cardiac Surgery and CHD and Pediatrics, Cardiac Surgery and Heart Failure, Congenital Heart Disease, CHD and Pediatrics and Arrhythmias, CHD and Pediatrics and Interventions, CHD and Pediatrics and Prevention, CHD and Pediatrics and Quality Improvement, Lipid Metabolism, Novel Agents, Statins, Acute Heart Failure, Interventions and Structural Heart Disease, Interventions and Vascular Medicine

Keywords: ACC Publications, Cardiology Magazine, COVID-19 Vaccines, Drug-Eluting Stents, Platelet Aggregation Inhibitors, Anticoagulants, Azithromycin, Enoxaparin, Factor XIa, Hydroxychloroquine, Venous Thromboembolism, Warfarin, Percutaneous Coronary Intervention, Centers for Medicare and Medicaid Services, U.S., Incidence, Accidental Falls, Arm, Arthroplasty, Replacement, Knee, Atrial Fibrillation, Benchmarking, COVID-19, COVID-19 Testing, Catalytic Domain, Foramen Ovale, Patent, Half-Life, Hospital Mortality, Myocarditis, Noncommunicable Diseases, Quality Improvement, Reading, Saliva, Medicare, Myocardial Infarction, Thrombosis, Registries, Primary Prevention, Venous Thrombosis, Nasopharynx, Hypersensitivity, Heart Failure, Long QT Syndrome, Budesonide, Hospitals, Stroke, Coronary Artery Bypass

< Back to Listings